Show simple item record

dc.contributor.advisorHruby, Victor J.en_US
dc.contributor.authorHan, Guoxia
dc.creatorHan, Guoxiaen_US
dc.date.accessioned2013-04-25T10:03:25Z
dc.date.available2013-04-25T10:03:25Z
dc.date.issued2000en_US
dc.identifier.urihttp://hdl.handle.net/10150/284287
dc.description.abstractA number of alpha-melanotropin (α-MSH) analogues have been designed de novo, synthesized and bioassayed at different melanocortin receptors from frog skins, mice and humans. These ligands were designed from two scaffolds, Somatostatin and Deltorphin-II, by two new hybrid approaches, one of which utilizes the modified cyclic structure (H-DPhe-Cys---Cys-Thr-NH₂) of a Somatostatin analogue--Sandostatin®, while the other incorporates the hydrophobic tail of Deltorphin-II (Glu-Val-Val-Gly-NH₂). Some of the ligands designed, H-DPhe-c [XXX-YYY-ZZZ-Arg-Trp-AAA]-Thr-NH₂ [XXX and AAA = Cys, DCys, Pen, DPen; YYY = His, His(1-Me), His(3-Me); ZZZ = Phe and side chain halogen substituted Phe, DPhe, DNal(1') and DNal(2 ')] and c[XXX-YYY-ZZZ-Arg-Trp-Glu]-Val-Val-Gly-NH₂ [XXX = nothing, Gly, β-Ala, γ-Abu, 6-Ahx; YYY = His, His(3-Bom), (S)-cyclopentylglycine (CPG); ZZZ = Phe, DPhe; DNal(2')], show unique selectivity and potency among the receptors tested. In particular, one of the ligands, Delt-38B--c[Gly-CPG-DNal(2')Arg-Trp-Glu]-Val-Val-Gly-NH₂, is a human melanocortin receptor (hMC1R) antagonist (IC₅₀ = 12 nM) the first potent hMC1R antagonist discovered. These results provide strong evidence supporting our hypothesis that ligand scaffolds for different G-protein coupled receptors (GPCRs) can be used to design ligands for other GPCRs. In addition, the structures of some of the ligands have been analyzed by high field solution NMR and their conformation evaluated by modeling with MacroModel. The conformations obtained from these methods help us better understand the structural basis the selectivities and ligand-receptor interactions.
dc.language.isoen_USen_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.subjectChemistry, Biochemistry.en_US
dc.subjectChemistry, Pharmaceutical.en_US
dc.titleDesign, synthesis, pharmacology, and structural analysis of bioactive melanocortin receptors' ligands by hybrid approachesen_US
dc.typetexten_US
dc.typeDissertation-Reproduction (electronic)en_US
thesis.degree.grantorUniversity of Arizonaen_US
thesis.degree.leveldoctoralen_US
dc.identifier.proquest9992118en_US
thesis.degree.disciplineGraduate Collegeen_US
thesis.degree.disciplineChemistryen_US
thesis.degree.namePh.D.en_US
dc.identifier.bibrecord.b41170696en_US
refterms.dateFOA2018-09-06T02:35:48Z
html.description.abstractA number of alpha-melanotropin (α-MSH) analogues have been designed de novo, synthesized and bioassayed at different melanocortin receptors from frog skins, mice and humans. These ligands were designed from two scaffolds, Somatostatin and Deltorphin-II, by two new hybrid approaches, one of which utilizes the modified cyclic structure (H-DPhe-Cys---Cys-Thr-NH₂) of a Somatostatin analogue--Sandostatin®, while the other incorporates the hydrophobic tail of Deltorphin-II (Glu-Val-Val-Gly-NH₂). Some of the ligands designed, H-DPhe-c [XXX-YYY-ZZZ-Arg-Trp-AAA]-Thr-NH₂ [XXX and AAA = Cys, DCys, Pen, DPen; YYY = His, His(1-Me), His(3-Me); ZZZ = Phe and side chain halogen substituted Phe, DPhe, DNal(1') and DNal(2 ')] and c[XXX-YYY-ZZZ-Arg-Trp-Glu]-Val-Val-Gly-NH₂ [XXX = nothing, Gly, β-Ala, γ-Abu, 6-Ahx; YYY = His, His(3-Bom), (S)-cyclopentylglycine (CPG); ZZZ = Phe, DPhe; DNal(2')], show unique selectivity and potency among the receptors tested. In particular, one of the ligands, Delt-38B--c[Gly-CPG-DNal(2')Arg-Trp-Glu]-Val-Val-Gly-NH₂, is a human melanocortin receptor (hMC1R) antagonist (IC₅₀ = 12 nM) the first potent hMC1R antagonist discovered. These results provide strong evidence supporting our hypothesis that ligand scaffolds for different G-protein coupled receptors (GPCRs) can be used to design ligands for other GPCRs. In addition, the structures of some of the ligands have been analyzed by high field solution NMR and their conformation evaluated by modeling with MacroModel. The conformations obtained from these methods help us better understand the structural basis the selectivities and ligand-receptor interactions.


Files in this item

Thumbnail
Name:
azu_td_9992118_sip1_m.pdf
Size:
3.912Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record